- Lobbying
- Ed AND Cox
Lobbying Arrangements Results for 'Ed Cox'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Broadband Data Mapping Geospatial data mapping, mapping of floodplains and hydrography AV technology as regards to base maps |
Sanborn Map Company
|
RPN Advocacy, LLC | |||
Details American Manufacturing Equity Act - to provide the same treatment FTA manufacturers received. |
RENFRO CORP.
|
SANDLER, TRAVIS & ROSENBERG, P.A. | |||
Details Disaster assistance/humanitarian relief Farm Bill; Food stamps Introduction of organization to lawmakers |
Islamic Relief USA
|
Prime Policy Group | |||
Details Community Health Centers funding and reauthorization; FY2025 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations process. |
Advocates for Community Health
|
Crossroads Strategies, LLC | |||
Details Issues related to health coverage for additional breast screenings for certain individuals at greater risk for breast cancer, H.R.3086, Find It Early Act. |
DenseBreast-info, Inc.
|
Crossroads Strategies, LLC | |||
Details Issues related to pandemic preparedness and strategic stockpile readiness, including state strategic stockpiles demonstration included in the PREVENT Act. Pandemic and All-Hazards Preparedness Act ... |
LifeScience Logistics
|
Crossroads Strategies, LLC | |||
Details Legislative issues related to mental health/severe mental illness; H.R.2617, Consolidated Appropriations Act, 2023 (P.L.117-328) implementation; FY2024 Departments of Labor, Health and Human Servic... |
Fountain House
|
Crossroads Strategies, LLC | |||
Details General education about end stage renal disease (ESRD) and kidney disease policies, including Medicare beneficiary access to pharmaceuticals. H.R.5074, Kidney PATIENT Act of 2023. General education... |
Vifor International AG (CSL Vifor)
|
Crossroads Strategies, LLC | |||
Details Medicare-funded Graduate Medical Education; NIH Osteopathic Funding and Representation; H.R.751, Fair Access in Residency Act; H.R.7258/S.3968, Community TEAMS Act of 2024; FY2025 National Defense ... |
American Association of Colleges of Osteopathic Medicine
|
Crossroads Strategies, LLC | |||
Details Issues related to overdose reversal products; H.R.2617, Consolidated Appropriations Act, 2023 (P.L.117-328) implementation; FY2024 Departments of Labor, Health and Human Services, and Education, an... |
Indivior Inc.
|
Crossroads Strategies, LLC | |||
Details General education to advance policies that support wastewater-based epidemiology and wastewater surveillance data analytic technology. General education to advance policies that support wastewater-... |
Biobot Analytics, Inc.
|
Crossroads Strategies, LLC | |||
Details Regulatory issues related to CBD; Farm Bill Reauthorization. |
Kazmira LLC
|
Crossroads Strategies, LLC | |||
Details General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Education about sickle cell disease therapy. General education about federal policies imp... |
Vertex Pharmaceuticals Incorporated
|
Crossroads Strategies, LLC | |||
Details Issues related to COVID-19 vaccines. Pandemic and All-Hazards Preparedness Act (PAHPA) including reauthorizing priority review vouchers. General discussions related to vaccine injury compensation p... |
NOVAVAX, INC.
|
Crossroads Strategies, LLC | |||
Details Issues related to healthcare and payment for over-the-counter drugs; FY2025 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations and FY2025 Departments ... |
Haleon US Holdings LLC (ffa GlaxoSmithKline Consumer Healthcare DBA Haleon)
|
Crossroads Strategies, LLC | |||
Details FY2024 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, H.R.4368/S.2131 - provisions related to the regulation of tobacco products. Issues rela... |
Altria Client Services LLC
|
Crossroads Strategies, LLC | |||
Details FDA's accelerated approval pathway; insulin price cap; H.R.830, HELP Copays Act; S.127, Pharmacy Benefit Manager Transparency Act of 2023; Pandemic and All-Hazards Preparedness Reauthorization Act ... |
Lilly USA, LLC
|
Crossroads Strategies, LLC | |||
Details Issues related to aviation and aerospace programs in the FY2024 National Defense Authorization Act, H.R.2670/S.2226, FY2024 Department of Defense Appropriations Act, H.R.4365/S.2587, FY2024 Transpo... |
The Boeing Company
|
Crossroads Strategies, LLC | |||
Details General education to advance policies that support innovation in the medical device industry. Issues related to coverage and reimbursement of diagnostic tests, including H.R.2369 the VALID Act of 2... |
Advanced Medical Technology Association (AdvaMed)
|
Crossroads Strategies, LLC | |||
Details Regulatory and legislative health care issues, including: Alzheimer's drug development; Drug Pricing; H.R.5378, Lower Costs, More Transparency Act; Pandemic and All-Hazards Preparedness Act (PAHPA)... |
Eisai, Inc.
|
Crossroads Strategies, LLC | |||
Details Issues related to health care, the Food and Drug Administration (FDA), oncology coverage, 340B Program, drug pricing, importation of biopharmaceuticals, insulin price cap, and international pharmac... |
Bristol-Myers Squibb
|
Crossroads Strategies, LLC | |||
Details 340B drug discount program; drug pricing; importation of biopharmaceuticals; direct-to-consumer (DTC) advertising; transparency; international pharmaceutical supply chain; antimicrobial resistance ... |
Pharmaceutical Research and Manufacturers of America
|
Crossroads Strategies, LLC | |||
Details Issues related to health care, the Food and Drug Administration (FDA), oncology coverage, mental health, opioid abuse, 340B Program, drug pricing, importation of biopharmaceuticals, insulin price c... |
Takeda Pharmaceuticals America, Inc.
|
Crossroads Strategies, LLC | |||
Details Issues related to health care, the Food and Drug Administration (FDA), oncology coverage, 340B Program, drug pricing, importation of biopharmaceuticals, international pharmaceutical supply chain, T... |
Merck & Co., Inc.
|
Crossroads Strategies, LLC | |||
Details Issues related to health care, the Food and Drug Administration (FDA), Rx-to-OTC switch issues, influenza, 340B Program, drug pricing, importation of biopharmaceuticals, international pharmaceutica... |
Sanofi US Services Inc.
|
Crossroads Strategies, LLC | |||
Details Aerospace to include space and satellite programs. Acquisition policy. Science programs. Spectrum - to include 5G. Data rights issues. FY24 NASA Authorization legislation. FY24 CJS Appropriations. ... |
BOEING COMPANY
|
in-house lobbying | |||
Details Work Opportunity Tax Credit (WOTC). Extension/enhancement of the Employee Retention Tax Credit (ERTC) and ERTC refund improvements. Tax rates, including corporate, individual, small business, and p... |
National Restaurant Association
|
in-house lobbying | |||
Details Farm Bill reauthorization issues; Title VII Research, Extension, and Related Matters programs; agriculture research and development issues; cooperative extension and capacity grant issues; NIFA agr... |
University of California
|
in-house lobbying | |||
Details HR 11, Freedom to Vote Act (Rep. Sarbanes, 213 cosponsors) HR 142, End Dark Money Act (Rep. Crow, 12 cosponsors) HR 153, Family Integrity to Reform Elections (FIRE) Act (Rep. Fallon, 1 cosponsor) H... |
COMMON CAUSE
|
in-house lobbying |